AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2007107 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg hyperbaric bupivacaine
Number of subjects: 27
Study 2007107 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hyperbaric bupivacaine
Number of subjects: 27
Study 7039758 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol
Number of subjects: 38
Study 7039758 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sherbet)
Number of subjects: 38
Study 7039758 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sherbet) from previous trial
Number of subjects: 38
Study 31449906 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior compartment peritonectomy
Number of subjects: 54
Study 28666476 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecure adults
Number of subjects: 0
Study 28666476 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecure children
Number of subjects: 0
Study 26580237 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 10194
Study 26580237 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 10194
Study 26580237 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 10194
Study 26580237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10194
Study 26580237 — intervention group
Group type: COMPARATOR
Intervention: Non-canagliflozin
Number of subjects: 10194
Study 24704684 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 1.2%/tretinoin 0.025% (Clin‐RA)
Number of subjects: 4550
Study 22070095 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan-based antihypertensive therapy
Number of subjects: 8831
Study 22070095 — intervention group
Group type: COMPARATOR
Intervention: Atenolol-based antihypertensive therapy
Number of subjects: 8831
Study 22070095 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol intake > 10 units/week
Number of subjects: 8831
Study 22070095 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 8831
Study 19182047 — intervention group
Group type: COMPARATOR
Intervention: Dancers
Number of subjects: 62
Study 19182047 — intervention group
Group type: COMPARATOR
Intervention: Persons with late blindness
Number of subjects: 62
Study 19182047 — intervention group
Group type: EXPERIMENTAL
Intervention: Amputation group
Number of subjects: 62
Study 19182047 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilization group
Number of subjects: 62
Study 19182047 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthesis use
Number of subjects: 62
Study 19182047 — intervention group
Group type: EXPERIMENTAL
Intervention: Amputation and immobilization groups
Number of subjects: 62
Study 19182047 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 17697911 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp50
Number of subjects: 10
Study 17697911 — intervention group
Group type: COMPARATOR
Intervention: BIAsp30
Number of subjects: 10
Study 15548795 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy plus 2.5% povidone‐iodine every 2 hours for 2 weeks
Number of subjects: 358
Study 15548795 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 358
Study 11676999 — intervention group
Group type: EXPERIMENTAL
Intervention: SEIQoL-DW
Number of subjects: 42
Study 11676999 — intervention group
Group type: COMPARATOR
Intervention: SIP
Number of subjects: 42
Study 11676999 — intervention group
Group type: COMPARATOR
Intervention: SF-36
Number of subjects: 42
Study 9625084 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents as agents of change (experimental group)
Number of subjects: 60
Study 9625084 — intervention group
Group type: COMPARATOR
Intervention: Children as agents of change (control group)
Number of subjects: 60
Study 17212003 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha ‐ 2b (Intron‐A) 3 million units (MU) subcutaneously thrice weekly for 6 months
Number of subjects: 38
Study 17212003 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with interferon)
Number of subjects: 38
Study 3124604 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms
Number of subjects: 30
Study 3124604 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate 1 g
Number of subjects: 30
Study 3124604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30738981 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 3 (Gini coefficient >41%)
Number of subjects: 15126
Study 30738981 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 3 (Gini coefficient >41%) after adjustments
Number of subjects: 15126
Study 29335048 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera-containing toothpaste
Number of subjects: 40
Study 29335048 — intervention group
Group type: COMPARATOR
Intervention: Triclosan toothpaste
Number of subjects: 40
Study 26717361 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX alone
Number of subjects: 114
Study 26717361 — intervention group
Group type: EXPERIMENTAL
Intervention: GOM+MTX
Number of subjects: 114
Study 26717361 — intervention group
Group type: COMPARATOR
Intervention: RA control
Number of subjects: 114
Study 22905897 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist focus on client commitment to change alcohol use
Number of subjects: 0
Study 22905897 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist focus on client ambivalence
Number of subjects: 0
Study 22905897 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal assessment
Number of subjects: 0
Study 21416235 — intervention group
Group type: EXPERIMENTAL
Intervention: Ningdong granule (NDG) 5 mg/kg/day
Number of subjects: 72
Study 21416235 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate 1 mg/kg/day
Number of subjects: 72
Study 19196218 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interview format
Number of subjects: 1090
Study 19196218 — intervention group
Group type: COMPARATOR
Intervention: Paper format
Number of subjects: 1090
Study 17907390 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture + Rehabilitation (Acup + Rehab)
Number of subjects: 40
Study 17907390 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation (Rehab)
Number of subjects: 40
Study 15066971 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence based training session on the risks associated with baby walkers
Number of subjects: 0
Study 12575494 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 20
Study 12575494 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (3 mg)
Number of subjects: 20
Study 12575494 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg)
Number of subjects: 20
Study 12575494 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 20
Study 9679365 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 1
Study 9679365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 7851625 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 131I adjusted to the patients' thyroid weight (group 1)
Number of subjects: 285
Study 7851625 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated lower dose of 131I (approximately 30Gy) (group 2)
Number of subjects: 285
Study 2697627 — intervention group
Group type: EXPERIMENTAL
Intervention: K-canrenoate
Number of subjects: 0
Study 2697627 — intervention group
Group type: COMPARATOR
Intervention: Spironolactone
Number of subjects: 0
Study 61564 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of urea, saline, and sodium bicarbonate; oral water load
Number of subjects: 4
Study 61564 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 4
Study 31606448 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) 20-min daily stimulation
Number of subjects: 70
Study 31606448 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) 2×20-min daily stimulation
Number of subjects: 70
Study 31606448 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 70
Study 31706325 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery training (EG)
Number of subjects: 40
Study 31706325 — intervention group
Group type: COMPARATOR
Intervention: Gait exercises (CG)
Number of subjects: 40
Study 28152167 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational Pain Management Protocol
Number of subjects: 128
Study 28152167 — intervention group
Group type: COMPARATOR
Intervention: Usual pain management strategies
Number of subjects: 128
Study 25823271 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy in addition to medical therapy
Number of subjects: 75
Study 25823271 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy only (Control Group 2)
Number of subjects: 75
Study 23604578 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement duration of 1,250 ms
Number of subjects: 10
Study 23604578 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement durations deviating from 1,250 ms
Number of subjects: 10
Study 23604578 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement duration
Number of subjects: 10
Study 21484319 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 80
Study 21484319 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 80
Study 19151052 — intervention group
Group type: COMPARATOR
Intervention: Normal tracheal tube orientation
Number of subjects: 200
Study 19151052 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse tracheal tube orientation
Number of subjects: 200
Study 17674576 — intervention group
Group type: EXPERIMENTAL
Intervention: whirlpool tub, jets on, using standard soap products
Number of subjects: 31
Study 17674576 — intervention group
Group type: EXPERIMENTAL
Intervention: ultrasound tub, ultrasound on, using standard soap products
Number of subjects: 31
Study 17674576 — intervention group
Group type: EXPERIMENTAL
Intervention: ultrasound tub, ultrasound on, using specialized soap and skin conditioner
Number of subjects: 31
Study 17674576 — intervention group
Group type: COMPARATOR
Intervention: either tub (randomized), water circulation off, using standard soap products
Number of subjects: 31
Study 17674576 — intervention group
Group type: EXPERIMENTAL
Intervention: ultrasound tub using enhanced skin cleansers
Number of subjects: 31
Study 17674576 — intervention group
Group type: EXPERIMENTAL
Intervention: ultrasound and whirlpool tubs
Number of subjects: 31
Study 15104658 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte apheresis (GA-1) after initial mobilization with glycosylated G-CSF 6.0 micro g per kg and oral dexamethasone (DXM, 8 mg)
Number of subjects: 111
Study 15104658 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte apheresis (GA-2) after remobilization with DXM
Number of subjects: 111
Study 15104658 — intervention group
Group type: EXPERIMENTAL
Intervention: Remobilization with DXM 8 mg
Number of subjects: 111
Study 15104658 — intervention group
Group type: EXPERIMENTAL
Intervention: Remobilization with DXM 4 mg
Number of subjects: 111
Study 15104658 — intervention group
Group type: EXPERIMENTAL
Intervention: Remobilization with DXM 1.5 mg
Number of subjects: 111
Study 15104658 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no remobilization)
Number of subjects: 111
Study 11844120 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak flow monitoring (PFM)
Number of subjects: 134
Study 11844120 — intervention group
Group type: COMPARATOR
Intervention: Symptom-based action plans
Number of subjects: 134
Study 11844120 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PFM and symptoms)
Number of subjects: 134
Study 11844120 — intervention group
Group type: EXPERIMENTAL
Intervention: All subjects with ED visits
Number of subjects: 134
Study 9781831 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg aspirin/day
Number of subjects: 56160
Study 9781831 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (30-300 mg/day)
Number of subjects: 56160
Study 9781831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56160
Study 9781831 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 56160
Study 9781831 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulants
Number of subjects: 56160
Study 17974384 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 0.25 mcg/day 1‐alpha‐OHD3 plus 10 mcg/day 24,25(OH)2D3
Number of subjects: 46
Study 17974384 — intervention group
Group type: COMPARATOR
Intervention: 1‐alpha‐OHD3 plus placebo
Number of subjects: 46
Study 17974384 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐alpha‐OHD3 plus 24,25(OH)2D3
Number of subjects: 46
Study 2681316 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.3 mg/kg
Number of subjects: 12
Study 2681316 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 1.0 mg/kg
Number of subjects: 12
Study 2681316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 823516 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium etidronate (EHDP)
Number of subjects: 149
Study 823516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 31678965 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer
Number of subjects: 180
Study 31678965 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Blood Pressure Monitoring (HBPM)
Number of subjects: 180
Study 31678965 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer + HBPM
Number of subjects: 180
Study 31678965 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 30137352 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P13 (biosimilar of infliximab)
Number of subjects: 810
Study 27651353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketoprofen
Number of subjects: 477
Study 27651353 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 477
Study 26152411 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidacloprid 10 % (w/w)/flumethrin 4.5 % (w/w) collar (Seresto)
Number of subjects: 0
Study 26152411 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluralaner (Bravecto) (dosage 25.1 - 49.4 mg/kg)
Number of subjects: 0
Study 26152411 — intervention group
Group type: COMPARATOR
Intervention: Non-treated controls
Number of subjects: 0
Study 23745274 — intervention group
Group type: EXPERIMENTAL
Intervention: NDT intervention (once per week from corrected age 1 month to 3 months, and 3 to 5 times per week for the following 9 months)
Number of subjects: 203
Study 23745274 — intervention group
Group type: EXPERIMENTAL
Intervention: NDT intervention
Number of subjects: 203
Study 23745274 — intervention group
Group type: COMPARATOR
Intervention: Control group (family intervention such as massage and exercise based on early education)
Number of subjects: 203
Study 21292633 — intervention group
Group type: EXPERIMENTAL
Intervention: 13‐cis‐retinoic acid (13‐cRA)
Number of subjects: 450
Study 21292633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 19735513 — intervention group
Group type: EXPERIMENTAL
Intervention: High flavanol (HF) chocolate, 20 g daily for 12 weeks
Number of subjects: 30
Study 19735513 — intervention group
Group type: COMPARATOR
Intervention: Low flavanol (LF) chocolate, 20 g daily for 12 weeks
Number of subjects: 30
Study 17023228 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release carvedilol (CR) 20 mg once daily
Number of subjects: 122
Study 17023228 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release carvedilol (IR) 6.25 mg twice daily
Number of subjects: 122
Study 17023228 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release carvedilol (CR) 80 mg once daily
Number of subjects: 122
Study 17023228 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release carvedilol (IR) 25 mg twice daily
Number of subjects: 122
Study 17023228 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release carvedilol (CR)
Number of subjects: 122
Study 17023228 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release carvedilol (IR)
Number of subjects: 122
Study 15931649 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal urokinase 60,000 IU
Number of subjects: 88
Study 15931649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 12811716 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside ultrasound performed by emergency physicians (EPs) after water ingestion in the right lateral decubitus (RLD) position
Number of subjects: 20
Study 12811716 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside ultrasound performed by emergency physicians (EPs) before water ingestion
Number of subjects: 20
Study 12811716 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside ultrasound performed by emergency physicians (EPs) in the supine position
Number of subjects: 20
Study 10357953 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant follicle stimulating hormone (rFSH)
Number of subjects: 30
Study 10357953 — intervention group
Group type: COMPARATOR
Intervention: urinary follicle stimulating hormone (uFSH)
Number of subjects: 30
Study 8569230 — intervention group
Group type: EXPERIMENTAL
Intervention: Ajmaline
Number of subjects: 0
Study 8569230 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 0
Study 8569230 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 0
Study 8569230 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 0
Study 8569230 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 0
Study 8569230 — intervention group
Group type: COMPARATOR
Intervention: Adenosine
Number of subjects: 0
Study 8569230 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine (NE)
Number of subjects: 0
Study 8569230 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study 8569230 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 0
Study 8569230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1904183 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 250 mg thrice daily for 4 weeks postoperatively
Number of subjects: 55
Study 1904183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 7205244 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills training with nonprofessional therapists
Number of subjects: 16
Study 7205244 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 16
Study 7205244 — intervention group
Group type: COMPARATOR
Intervention: Inert placebo
Number of subjects: 16
Study 28657333 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-minute intervention session
Number of subjects: 16
Study 28657333 — intervention group
Group type: COMPARATOR
Intervention: Theory-based time-and-attention control session focused on diet and nutrition
Number of subjects: 16
Study 27632816 — intervention group
Group type: COMPARATOR
Intervention: Pre-invitation leaflet and online booking
Number of subjects: 20905
Study 27632816 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal self-sampling kits (SSKs) sent unrequested
Number of subjects: 20905
Study 27632816 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed appointments
Number of subjects: 20905
Study 27632816 — intervention group
Group type: EXPERIMENTAL
Intervention: Offer of a nurse navigator (NN)
Number of subjects: 20905
Study 27632816 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal self-sampling kits (SSKs) on request
Number of subjects: 20905
Study 27632816 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice between a NN or a SSK
Number of subjects: 20905
Study 27632816 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccination
Number of subjects: 20905
Study 27632816 — intervention group
Group type: EXPERIMENTAL
Intervention: Health economic analysis of timed appointments and unsolicited SSKs
Number of subjects: 20905
Study 23486755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral training and automated phone calls (6 sessions, 90 mins each, weekly; phone calls twice daily for 1 year)
Number of subjects: 70
Study 23486755 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 24429855 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative antiseptic treatment of the operative field
Number of subjects: 202
Study 24429855 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antiseptic washing of the nasopharynx
Number of subjects: 202
Study 20795423 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education workshop
Number of subjects: 210
Study 20795423 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 210
Study 18492760 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative octreotide treatment (20 mg im every 28th day for 6 months)
Number of subjects: 62
Study 18492760 — intervention group
Group type: COMPARATOR
Intervention: Direct surgery
Number of subjects: 62
Study 18492760 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative octreotide treatment (20 mg im every 28th day for 6 months) in patients with macroadenomas
Number of subjects: 62
Study 18492760 — intervention group
Group type: COMPARATOR
Intervention: Direct surgery in patients with macroadenomas
Number of subjects: 62
Study 16517952 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-valve device
Number of subjects: 360
Study 16517952 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-pressure-valve device flushed with heparinized saline
Number of subjects: 360
Study 16517952 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-pressure-valve device flushed with saline
Number of subjects: 360
Study 16517952 — intervention group
Group type: COMPARATOR
Intervention: Standard device
Number of subjects: 360
Study 12975720 — intervention group
Group type: EXPERIMENTAL
Intervention: [(14)C]M100240 (25 mg, 50 microCi) as an oral solution under fasting conditions
Number of subjects: 0
Study 10753272 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic foot compression (IPC(foot)) for >4 hr/d for 4.5 months (group 1)
Number of subjects: 37